🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Acquisition of Full Oral Feeding and Further Oral Disorders in Extremely Preterm Infants

Recruitingn/aAges any - 28 WeeksAllHospices Civils de Lyon
NCT06648083 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Extremely premature infants (born before 29 weeks) frequently present oral disorders. The management of these patients require assisted ventilation, enteral nutrition, and intensive daily care (procedural pain, exposure to pain, noise, and light), which can have a negative impact on their development. And more specifically on the development of oral skills. In the past decades, the standard of care has evolved and is based on less "aggressive" care and the implication of parents as caregivers. Recent data on the incidence of oral disorders in extremely premature babies are not currently available. These oral disorders have significant short-term and long-term consequences. During hospitalization, it leads to a delay in the acquisition of full oral feeding, which is defined as the absence of need for tube feeding, and is associated with prolonged hospitalization. It is also associated wi

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Infants born at a gestational age ≤ 28 weeks * Born between January 1, 2018 and December 31, 2021 * Admitted in the first three days of life in the neonatology department of the Croix-Rousse hospital * Discharged directly to home (or to a nursery) Exclusion Criteria: * Infants re-transferred to another department during hospitalization * Infants with a severe pathology requiring surgical management in the first weeks of life. Inguinal hernia repair is not concerned * Severe malformation * Refusal of the parents
💊

What it tests

  • Food autonomy
📍

Where

1 site
Hopital Croix Rousse
Lyon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy